In vitro characterization of natural and synthetic dermal matrices cultured with human dermal fibroblasts

Biomaterials

Volumn 25, Issue 14, 2004, Pages 2807-2818

  Ng, K W ^a   Khor, H L ^a   Hutmacher, D W ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Dermal replacement; Human dermal fibroblasts; Natural and synthetic matrices; Tissue engineering

Indexed keywords

BIOASSAY; CELLS; ELECTRON MICROSCOPY; HISTOLOGY; MORPHOLOGY; TISSUE;

EXTRACELLULAR MATRICES (ECM); METABOLIC ACTIVITY;

DERMATOLOGY;

CHITOSAN; COLLAGEN; GLYCOLIC ACID; LACTONE DERIVATIVE; THYMIDINE; TRITIUM;

CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONFOCAL LASER MICROSCOPY; DERMIS; DNA DETERMINATION; DNA SYNTHESIS; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METABOLISM; MUSCLE FIBER CONTRACTION; POROSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE ENGINEERING;

EQUIDAE;

EID: 1042298996     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2003.09.058     Document Type: Conference Paper

References (39)

1. Cairns B.A., deSerres S., Peterson H.D., Meyer A.A. Skin replacements. the biotechnological quest for optimal wound closure Arch Surg. 128:1993;1246-1252.
2. Kirsner R.S., Falanga V., Eaglstein W.H. The development of bioengineered skin. Trends Biotechnol. 16:1998;246-249.
3. Hardin-Young J., Parenteau N.L. Bilayered skin constructs. Atala A., Lanza R.P. Methods of tissue engineering. 2002;1177-1188 Academic Press, California.
4. Burke J.F., Yannas I.V., Quinby W.C. Jr., Bondoc C.C., Jung W.K. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg. 194:1981;413-428.
5. Lorenz Ch., Petracic A., Hohl H-.P., Wessel L., Waag K-.L. Early wound closure and early reconstruction. Experience with a dermal substitute in a child with 60 per cent surface area burn. Burns. 27:1997;505-508.
6. Bell E., Ehrlich H.P., Buttle D.J., Nakatsuji T. Living tissue formed in vitro and accepted as skin equivalent tissue of full-thickness. Science. 211:1981;1052-1054.
7. Bell E., Ivarsson B., Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Nat Acad Sci USA. 76(3):1979;1274-1278.
8. Spector M. Novel cell-scaffold interactions encountered in tissue engineering. contractile behaviour of musculoskeletal connective tissue cells Tissue Eng. 8(3):2002;351-357.
9. Kofidis T., Akhyari P., Wachsmann B., Mueller-stahl K., Boublik J., Ruhparwar A., Mertsching H., Balsam L., Robbins R., Haverich A. Clinically established hemostatic scaffold (tissue fleece) as biomatrix in tissue- and organ-engineering research. Tissue Eng. 9(3):2003;517-523.
10. Livesey SA, del Campo AA, Nag A, Nichols KB, Coleman C. United States Patent No. 5336616 (1994), 2-15.
11. Sclafani A.P., Romo T. III, Jacono A.A., McCormick S., Cocker R., Parker A. Evaluation of acellular dermal graft in sheet (AlloDerm) and injectable (micronized AlloDerm) forms for soft tissue augmentation Clinical observations and histological analysis. Arch Facial Plast Surg. 2(2):2000;130-136.
12. Sinha U.K., Shih C., Chang K., Rice D.H. Use of AlloDerm for coverage of radial forearm free flap donor site. Laryngoscope. 112(2):2002;230-234.
13. Rennekampff H.O., Pfau M., Schaller H.E. Acellular allograft dermal matrix. immediate or delayed epidermal coverage? Burns. 28(1):2002;100-101.
14. Rao S.B., Sharma C.P. Use of chitosan as a biomaterial. studies on its safety and hemostatic potential J Biomed Mater Res. 34:1997;21-28.
15. Hirano S., Tsuchida H., Nagao N. N-acetylation in chitosan and the rate of its enzymatic hydrolysis. Biomaterials. 10:1989;574-576.
16. Shigemasa Y., Minami S. Applications of chitin and chitosan for biomaterials. Biotechnol Genet Eng Rev. 13:1996;383-420.
17. Muzzarelli R.A., Mattioli-Belmonte M., Pugnaloni A., Biagini G. Biochemistry, histology and clinical uses of chitins and chitosans in wound healing. EXS. 87:1999;251-264.
18. Chung L.Y., Schmidt R.J., Hamlyn P.F., Sager A.M., Andrews A.M., Turner T.D. Biocompatibility of potential wound management products. fungal mycelia as a source of chitin/chitosan and their effects on the proliferation of human F1000 fibroblasts in culture J Biomed Mater Res. 28:1994;463-469.
19. Mori T., Okumura M., Matsuura M., Ueno K., Tokura S., Okamoto Y., Minami S., Fujinaga T. Effects of chitin and its derivatives on the proliferation and cytokine production of fibroblasts in vitro. Biomaterials. 18:1997;947-951.
20. Gentzkow G.D., Iwasaki S.D., Hershon K.S., Mengel M., Prendergast J.J., Ricotta J.J., Steed D.P., Lipki S. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care. 4:1996;350-354.
21. Naughton G., Mansbridge J., Gentzkow G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Org. 21(11):1997;1203-1210.
22. Ouyang H.W., Goh J.C.H., Mo X.M., Teoh S.H., Lee E.H. The efficacy of bone marrow stromal cell-seeded knitted PLGA fibre scaffold for achilles tendon repair. Ann NY Acad Sci. 961:2002;126-129.
23. Ang T.H., Sultana F.S.A., Hutmacher D.W., Wong Y.S., Fuh J.Y.H., Mo X.M., Loh H.T., Burdet E., Teoh S.H. Fabrication of 3D chitosan-hydroxyapatite scaffolds using a robotic dispensing system. Sci Eng C. 20:2002;35-42.
24. Lamme E.N., Van Leeuwen R.T.J., Brandsma K., Van Marle J., Middelkoop E. Higher numbers of autologous fibroblasts in an artificial dermal substitute improve tissue regeneration and modulate scar tissue formation. J Pathol. 190:2000;595-603.
25. Saltzman W.M., Olbricht W.L. Building drug delivery into tissue engineering. Nature Reviews. 1:2002;177-186.
26. Chaignaud B.E., Langer R., Vacanti J.P. The history of tissue engineering using synthetic biodegradable polymer scaffolds and cells. Atala A., Mooney D. Synthetic biodegradable polymer scaffolds. 1997;1-14 Birkhäuser, Boston.
27. Freed L.E., Vunjak-Novakovic G., Biron R.J., Eagles D.B., Lesnoy D.C., Barlow S.K., Langer R. Biodegradable polymer scaffolds for tissue engineering. Biotechnology. 12:1994;689-693.
28. Hutmacher D.W., Vanscheidt W. Matrices for tissue-engineered skin. Drugs Today. 38(2):2002;113-133.
29. Howling G.I., Dettmar P.W., Goddard P.A., Hampson F.C., Dornish M., Wood E.J. The effect of chitin and chitosan on the proliferation of human skin fibroblasts and keratinocytes in vitro. Biomaterials. 22:2001;2959-2966.
30. Clark R.A.F. Overview and general considerations of wound repair. Clark R.A.F., Henson P.M. The molecular and cell biology of wound repair. 1998;3-23 Plenum Press, New York.
31. Majno G., Gabbiani G., Hirschel B.J., Ryan G.B., Statkov P.R. Contraction of granulation tissue in vitro. similarity to smooth muscle Science. 173:1971;548-550.
32. Geesin J.C., Brown L.J., Liu Z., Berg R.A. Development of a skin model based on insoluble fibrillar collagen. J Biomed Mater Res. 33(1):1996;1-8.
33. Chen G., Ushida T., Tatsuya T. A biodegradable hybrid sponge nested with collagen microspheres. J Biomed Mater Res. 51:2000;273-279.
34. Imaizumi T., Jean-Louis F., Dubertret M-.L., Bailly C., Cicurel L., Petchot-Bacque J-.P., Dubertret L. Effect of human basic fibroblast growth factor on fibroblast proliferation, cell volume, collagen lattice contraction. in comparison with acidic type J Dermatol Sci. 11:1996;134-141.
35. Ojeh N.O., Frame J.D., Navsaria H.A. In vitro characterization of an artificial scaffold. Tissue Eng. 7(4):2001;457-472.
36. Terino E.O. Alloderm acellular dermal graft. applications in aesthetic soft-tissue augmentation Clin Plast Surg. 28(1):2001;83-99.
37. Naughton G.K., Applegate D.R. Cryopreserved dermal implants. Atala A., Lanza R.P. Methods of tissue engineering. 2002;1157-1175 Academic Press, California.
38. Naughton G., Mansbridge J., Gentzkow G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Org. 21(11):1997;1203-1210.
39. Mansbridge J., Liu K., Patch R., Symons K., Pinney E. Three-dimensional fibroblast culture implant for the treatment of diabetic foot ulcers. metabolic activity and therapeutic range Tissue Eng. 4(4):1998;403-414.